Securities code: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) securities abbreviation: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) Announcement No.: 2022021
Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864)
Announcement of resolutions of the 21st Meeting of the third board of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of directors
1. Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) (hereinafter referred to as “the company”) the notice of the 21st Meeting of the third board of directors was sent to all directors by email on March 28, 2022.
2. The meeting was held at 9:30 a.m. on March 31, 2022 in the conference room on the second floor of Shaanxi Panlong Pharmaceutical Co., Ltd., No. 2801, Baliu Second Road, modern textile industrial park, Baqiao District, Xi’an. The meeting was conducted by combining on-site and communication.
3. At this meeting, there are 9 directors who should vote and 9 directors who actually vote. Among them, Mr. Li Junde, an independent director, participated in the voting by means of communication.
4. Mr. Xie Xiaolin, chairman of the company, presided over the meeting.
5. The notice, convening and convening of this meeting comply with the company law of the people’s Republic of China and other laws, administrative regulations, departmental rules, normative documents and the relevant provisions of Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) articles of association.
2、 Deliberations of the board meeting
(I) deliberated and passed the proposal on the company’s use of idle raised funds for cash management; For details, please refer to China Securities News, Shanghai Securities News, securities times, securities daily and cninfo.com published on the same day（ http://www.cn.info.com.cn. ）The announcement of Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) on the company’s use of idle raised funds for cash management (Announcement No.: 2022023) disclosed.
The independent directors of the company gave consent to the matter, and the recommendation institution issued special verification opinions on it. See details published on cninfo.com on the same day（ http://www.cn.info.com.cn. ）The independent opinions of Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) independent directors on the deliberation of relevant matters at the 21st Meeting of the third board of directors and Zhongtai Securities Co.Ltd(600918) on the verification opinions of Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) using idle raised funds for cash management disclosed.
Review results: 9 votes, 9 affirmative votes, 0 negative votes and 0 abstention votes.
Independent directors have expressed their independent opinions.
(II) deliberated and passed the proposal on applying for 100 million yuan short-term working capital loan from Bank Of China Limited(601988) Xi’an high tech Development Zone sub branch and providing guarantee to the actual controller of the company;
Proposal content: for the further development of the company, the company plans to apply to Bank Of China Limited(601988) Xi’an high tech Development Zone sub branch for a loan of 100 million yuan for daily operation, with a loan term of one year, and the actual controller Xie Xiaolin and his spouse provide joint and several liability guarantee.
Review results: 9 votes, 9 affirmative votes, 0 negative votes and 0 abstention votes.
Independent directors have expressed their independent opinions.
3、 Documents for future reference
1. Resolutions of the 21st Meeting of the third board of directors of the company;
2. Other documents required by SZSE.
Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) board of directors April 1, 2022
